From: Efficacies of DHA–PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan
Outcome
DHA–PPQ (N%) (95% CI)
AS/SP (N%) (95% CI)
ETF
0 (0%) (0.0–6.5)
1 (1.6%) (0.0–8.8)
LCF
1 (1.8%) (0.0–9.7)
0 (0%) (0.0–5.9)
LPF
9 (14.8%) (7–26.2)
ACPR
54 (98.2%) (90.3–100)
51 (83.6%) (71.9–91.8)
Total
55
61